Fabian Hauswirth

Spital Thurgau (Switzerland)

Papers

1

Total Citations

41

H-Index

1

About

Fabian Hauswirth is a leading voice in the evolution of pancreatic surgery, with a focused research agenda on comparing minimally invasive techniques—both laparoscopic and robotic—against traditional open procedures. His most impactful work, a 2023 meta-analysis of randomized clinical trials, has already garnered 41 citations, underscoring its timely relevance to a field grappling with the challenges of widespread adoption. In this landmark study, Hauswirth synthesized high-level evidence to evaluate perioperative outcomes, providing crucial clarity on the safety, efficacy, and recovery benefits of minimally invasive approaches. Beyond this meta-analysis, his broader contributions center on refining surgical protocols and advancing evidence-based decision-making for complex pancreatic resections. By systematically addressing the barriers to implementation—such as steep learning curves and variable patient outcomes—Hauswirth’s research directly informs clinical practice and surgical training. His work is particularly notable for bridging the gap between emerging technology and real-world application, making him a key figure for students and researchers interested in the future of hepatopancreatobiliary surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive<i>versus</i>open pancreatic surgery: meta-analysis of randomized clinical trials
41 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Spital Thurgau (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago